The FAERS Public Dashboard and its Value to the Pharmaceutical Industry
Jul 31, 2018 - 00:24:45
Radio and PodcastLive Radio & PodcastsHealth
FDA D.I.S.C.O.: First Biosimilar Approval for the Treatment of Cancer
Oncologists Dr. Sanjeeve Bala and Dr. Abhilasha Nair from FDA’s Oncology Center of Excellence discuss the recent approval of bevacizumab-awwb, a biosimilar to US-licensed Avastin, marketed as MVASI. MVASI is the first bi...
About This Episode
FDA D.I.S.C.O.: First Biosimilar Approval for the Treatment of Cancer is an episode from FDA Drug Information Updates by ReachMD. Oncologists Dr. Sanjeeve Bala and Dr. Abhilasha Nair from FDA’s Oncology Center of Excellence discuss the rece...
Podcast
This episode belongs to FDA Drug Information Updates.
Listen Online
Use the player on this page to stream the episode online.
Episode Details
Published Jan 7, 2018, 00:08:29 long, audio available.
Related Episodes
Continue listening to more episodes from FDA Drug Information Updates.
FDA Warns of Serious Immune Reaction with Seizure/BPD Medicine Lamotrigine (Lamictal)
May 4, 2018 - 00:02:59
FDA Requires New Class Warnings for All Gadolinium-Based Contrast Agents
Jan 5, 2018 - 00:02:59
The FDA's Adverse Event Reporting System (FAERS) Public Dashboard
Oct 29, 2017 - 00:09:22
FDA D.I.S.C.O.: L-Glutamine for Sickle Cell Disease
Aug 17, 2017 - 00:05:29
FDA D.I.S.C.O.: Osimertinib for Non-Small Cell Lung Cancer
Jul 28, 2017 - 00:06:00
FDA D.I.S.C.O.: Two Approvals for ALK-Positive Non-Small Cell Lung Cancer
Jul 25, 2017 - 00:09:00
Questions About This Episode
What is FDA D.I.S.C.O.: First Biosimilar Approval for the Treatment of Cancer about?
Oncologists Dr. Sanjeeve Bala and Dr. Abhilasha Nair from FDA’s Oncology Center of Excellence discuss the recent approval of bevacizumab-awwb, a biosimilar to US-licensed Avastin, marketed as MVASI. MVASI is the first biosimilar approved in the US for the treatment of cancer. Released on December 21, 2017
Where can I listen to FDA D.I.S.C.O.: First Biosimilar Approval for the Treatment of Cancer?
You can listen to FDA D.I.S.C.O.: First Biosimilar Approval for the Treatment of Cancer online on Radio and Podcast. Open the player on this page to stream the available audio.
Which podcast is FDA D.I.S.C.O.: First Biosimilar Approval for the Treatment of Cancer from?
FDA D.I.S.C.O.: First Biosimilar Approval for the Treatment of Cancer is an episode from FDA Drug Information Updates by ReachMD.
How long is this episode?
This episode is 00:08:29 long.
When was this episode published?
This episode was published on Jan 7, 2018.
Can I save FDA D.I.S.C.O.: First Biosimilar Approval for the Treatment of Cancer for later?
Yes. Use the heart button on the episode page to add it to your favorite episodes list.
Are there related episodes from FDA Drug Information Updates?
Yes. This page shows related episodes from FDA Drug Information Updates when more episodes are available from the podcast feed.
Quick Answers About This Episode
Where can I listen to FDA D.I.S.C.O.: First Biosimilar Approval for the Treatment of Cancer?
You can listen to FDA D.I.S.C.O.: First Biosimilar Approval for the Treatment of Cancer on this page when the episode audio is available from the podcast feed.
Which podcast is this episode from?
FDA D.I.S.C.O.: First Biosimilar Approval for the Treatment of Cancer is from FDA Drug Information Updates by ReachMD.
What are the episode details?
Published Jan 7, 2018 and 00:08:29 long